Stock RGLS REGULUS THERAPEUTICS INC.
Add to a list
To use this feature you must be a member
Log inSign up

Calendar Regulus Therapeutics Inc.

Equities

RGLS

US75915K3095

Market Closed - Nasdaq
Other stock markets
 01:30:00 27/04/2024 am IST 		5-day change 1st Jan Change
2.42 USD +6.61% Intraday chart for Regulus Therapeutics Inc. +13.62% +89.06%
21/03 Regulus Therapeutics Inc. Reports Earnings Results for the Full Year Ended December 31, 2023 CI
21/03 Regulus Therapeutics Inc. Reports Earnings Results for the Fourth Quarter Ended December 31, 2023 CI

Chart calendar Regulus Therapeutics Inc.

db981e028475f8.LQKrsDqOILC3Ks0n0ZU2C3iBUJb7ASRp4iBj-4NzAmY.ZjPzwGXvdfH0XaEUkqBYRAKsYN_MXm9bjBE0mbU7UzVoZ-P5cdtvg_NHhA~26648ace0808300811603a4bc2510d01

Upcoming events on Regulus Therapeutics Inc.

09/05/2024 Q1 2024 Earnings Release (Projected)
08/08/2024 Q2 2024 Earnings Release (Projected)
07/11/2024 Q3 2024 Earnings Release (Projected)
08/05/2025 Q1 2025 Earnings Release (Projected)

Past events on Regulus Therapeutics Inc.

22/03/2024 01:35 am Q4 2023 Earnings Release
12/03/2024 06:00 pm Business Update Call
05/01/2024 Investor Meeting After hours
29/11/2023 08:55 pm Evercore ISI HealthCONx Conference
10/11/2023 02:35 am Q3 2023 Earnings Release
20/09/2023 06:00 pm RGLS8429 Phase 1b Study Results Call
11/09/2023 08:30 pm H.C. Wainwright Global Investment Conference
06/09/2023 08:30 pm R&D Day
06/09/2023 Wells Fargo Healthcare Conference
09/08/2023 09:00 pm Canaccord Genuity Growth Conference
09/08/2023 01:35 am Q2 2023 Earnings Release
26/07/2023 12:30 am H.C. Wainwright Kidney Conference
01/06/2023 09:30 pm Annual General Meeting
12/05/2023 01:35 am Q1 2023 Earnings Release
24/03/2023 01:35 am Q4 2022 Earnings Release
09/03/2023 Chronic Kidney Disease Drug Development Summit
16/02/2023 11:30 pm SVB Securities Global Biopharma Conference
11/11/2022 03:30 am Q3 2022 Earnings Call
11/11/2022 02:35 am Q3 2022 Earnings Release
03/11/2022 07:30 pm American Society of Nephrology Kidney Week Conference - Abstract Number: 3768400

Annual results

Fiscal PeriodDecember 2019 2020 2021 2022 2023 2024
Net sales
Million USD		Released
Forecast
Spread 		6,83
6,86
-0.38%		10,0
5,02
99.28%		0,00
0,00
- 		0,00
0,00
- 		0,00
0,00
-
0,00

EBITDA
Million USD		Released
Forecast
Spread 		0,00
0,00
- 		0,00
0,00
- 		0,00
0,00
- 		0,00
0,00
- 		-30,9
-30,7
-0.59%
-38,7

EBIT
Million USD		Released
Forecast
Spread 		-16,8
-17,2
2.18%		-14,2
-19,2
26.36%		-27,8
-27,4
-1.42%		-28,2
-28,9
2.15%		-31,1
-30,9
-0.82%
-34,9

Earnings before Tax (EBT)
Million USD		Released
Forecast
Spread 		-18,6
-18,9
1.85%		-15,7
-20,9
24.88%		-27,8
-26,9
-3.43%		-28,3
-29,1
2.67%		-30,0
-29,9
-0.47%
-34,4

Net income
Million USD		Released
Forecast
Spread 		-18,6
-18,9
1.85%		-15,7
-20,9
24.86%		-27,8
-26,9
-3.43%		-28,3
-29,1
2.67%		-30,0
-30,0
-0.13%
-33,7

EPS
USD		Released
Forecast
Spread 		-10,8
-11,0
1.82%		-4,50
-6,60
31.82%		-3,20
-3,27
2.04%		-1,86
-1,83
-1.82%		-1,58
-1,59
0.32%
-0,51

Announcement Date12/03/2009/03/2110/03/2223/03/2321/03/24-

Quarterly results

Fiscal PeriodDecember 2021 Q4 2022 Q1 2022 Q2 2022 Q3 2022 Q4 2023 Q1 2023 Q2 2023 Q3 2023 Q4 2024 Q1 2024 Q2 2024 Q3 2024 Q4 2025 Q1
Net sales
Million USD		Released
Forecast
Spread 		0,00
0,00
- 		0,00
0,00
- 		0,00
0,00
- 		0,00
0,00
- 		0,00
0,00
- 		0,00
0,00
- 		0,00
0,00
- 		0,00
0,00
- 		0,00
0,00
-
0,00


0,00


0,00


0,00


0,00

EBIT
Million USD		Released
Forecast
Spread 		-6,96
-6,57
-5.9%		-6,57
-7,21
8.84%		-7,18
-7,05
-1.77%		-7,56
-7,35
-2.9%		-6,93
-7,66
9.5%		-7,37
-7,08
-4.16%		-7,32
-7,51
2.55%		-8,13
-7,51
-8.19%		-8,30
-8,05
-3.11%
-8,70


-8,70


-9,55


-9,55




Earnings before Tax (EBT)
Million USD		Released
Forecast
Spread 		-7,13
-6,14
-16.24%		-6,72
-7,20
6.75%		-7,26
-7,14
-1.67%		-7,55
-7,39
-2.13%		-6,80
-7,70
11.75%		-7,14
-6,99
-2.1%		-7,01
-7,34
4.41%		-7,82
-7,31
-6.99%		-8,06
-7,91
-1.94%
-8,56


-8,46


-9,33


-9,39




Net income
Million USD		Released
Forecast
Spread 		-7,13
-6,14
-16.24%		-6,72
-7,20
6.73%		-7,26
-7,14
-1.67%		-7,55
-7,39
-2.13%		-6,80
-7,70
11.75%		-7,14
-6,99
-2.1%		-7,01
-7,34
4.39%		-7,82
-7,31
-6.99%		-8,06
-8,01
-0.7%
-8,07


-8,11


-8,92


-9,22




EPS
USD		Released
Forecast
Spread 		-0,70
-0,67
-5%		-0,50
-0,53
6.25%		-0,50
-0,49
-3.09%		-0,50
-0,49
-2.04%		-0,40
-0,51
21.57%		-0,42
-0,44
3.82%		-0,37
-0,41
9.76%		-0,40
-0,40
-0.84%		-0,40
-0,40
-1.27%
-0,22


-0,11


-0,12


-0,12


-0,14

Announcement Date10/03/2212/05/2211/08/2210/11/2223/03/2311/05/2308/08/2309/11/2321/03/24-----

Upcoming sector events for Regulus Therapeutics Inc.

29/04/2024 HITGEN INC.: Q1 2024 Earnings Release (Projected)
29/04/2024 CASSAVA SCIENCES, INC.: Q1 2024 Earnings Release (Projected)
30/04/2024 DIZAL (JIANGSU) PHARMACEUTICAL CO., LTD.: Q4 2023 Earnings Release
30/04/2024 ARVINAS, INC.: Q1 2024 Earnings Release (Projected)
30/04/2024 MABWELL (SHANGHAI) BIOSCIENCE CO., LTD.: Q1 2024 Earnings Release
30/04/2024 WUXI APPTEC CO., LTD.: Q1 2024 Earnings Release
01/05/2024 01:35 am EXELIXIS, INC.: Q1 2024 Earnings Release
01/05/2024 SUMMIT THERAPEUTICS INC.: Q1 2024 Earnings Release
01/05/2024 MACROGENICS, INC.: Q1 2024 Earnings Release (Projected)
01/05/2024 REGENXBIO INC.: Q1 2024 Earnings Release (Projected)
More events

Past sector events for Regulus Therapeutics Inc.

26/04/2024 INVENTISBIO CO., LIMITED: Q4 2023 Earnings Release
26/04/2024 SHANGHAI MEDICILON INC.: Q1 2024 Earnings Release (Projected)
26/04/2024 SHANGHAI ALLIST PHARMACEUTICALS CO., LTD.: Q1 2024 Earnings Release (Projected)
26/04/2024 DIZAL (JIANGSU) PHARMACEUTICAL CO., LTD.: Q1 2024 Earnings Release (Projected)
26/04/2024 SHANGHAI ALLIST PHARMACEUTICALS CO., LTD.: Q4 2023 Earnings Release
26/04/2024 REMEGEN CO., LTD.: Q1 2024 Earnings Release
26/04/2024 01:35 am PTC THERAPEUTICS, INC.: Q1 2024 Earnings Release
25/04/2024 04:00 pm SAGE THERAPEUTICS, INC.: Q1 2024 Earnings Release
25/04/2024 JIANGSU YAHONG MEDITECH CO., LTD.: Q1 2024 Earnings Release (Projected)
25/04/2024 BIO-THERA SOLUTIONS, LTD.: Q1 2024 Earnings Release (Projected)

Net sales - Quarter - Rate of surprise

Quarterly earnings - Rate of surprise

Net sales - Annual - Rate of surprise

Annual profits - Rate of surprise

  1. Stock Market
  2. Equities
  3. RGLS Stock
  4. Calendar Regulus Therapeutics Inc.